M‑89
M-89 inhibits the menin-mixed lineage leukemia (Menin-MLL) protein-protein interaction and has potential to treat MLL leukemia. M-89 is a highly potent and specific menin inhibitor, with a Kd of 1.4 nM for binding to menin.
Product Specifications
CAS Number
2363165-42-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
657.86
Molecular Formula
C37H47N5O4S
Notes
Research use only, not for human use.
Receptor
Menin-MLL
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62553R-APC-01 20 µL
ADRA1A Recombinant Antibody, APC Conjugated
Sign In for Pricing
View Details bsm-62553R-APC-02 100 µL
ADRA1A Recombinant Antibody, APC Conjugated
Sign In for Pricing
View Details